Fate Therapeutics Announces FDA Clearance of IND Application for World’s First Cell Therapy Derived from an Engineered Pluripotent Stem Cell Read more
Cannabics and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics Read more
Taiho and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor Read more